Table 3.
Adjusted odds ratio for HOMA-IR-positive by IL-1β in 79 non-diabetic hemodialysis patients.
| Model 1a | Model 2 b | Model 3 c | ||||
|---|---|---|---|---|---|---|
| OR(95% CI) | p value | OR(95% CI) | p value | OR(95% CI) | p value | |
| Continuous: IL-1β each 0.01 pg/ml increase | ||||||
| 1.07 (1.03–1.12) | <0.001 | 1.07 (1.03–1.12) | <0.001 | 1.09 (1.04–1.16) | <0.001 | |
| Categorical: IL-1β lower group reference | ||||||
| IL-1β higher group | 12.55 (4.19–37.65) | <0.001 | 13.44 (4.27–42.34) | <0.001 | 26.09 (4.01–169.87) | <0.001 |
CI – confidence interval; OR – odds ratio.
a
Model 1 adjusted for age and gender;
b
Model 2 adjusted for model 1 variables; BMI – hypertension and cardiovascular disease;
c
Model 3 adjusted for model 2 variables, hemoglobin, C-reactive protein and ferritin.
*
IL-1β higher group and IL-1β lower group are stratified by IL-1β median.